C-reactive protein concentration as a significant correlate for metabolic syndrome: A Chinese population-based study

Endocrine

Volumn 43, Issue 2, 2013, Pages 351-359

  Yang, Tsan ^a   Chu, Chi Hong ^b   Hsieh, Po Chien ^c   Hsu, Chih Hsung ^c   Chou, Yu Ching ^c   Yang, Shih Hsien ^c   Bai, Chyi Huey ^d   You, San Lin ^e   Hwang, Lee Ching ^f   Chung, Tieh Chi ^a   Sun, Chien An ^g  

^a MEIHO UNIVERSITY   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e GENOMICS RESEARCH CENTER   (Taiwan)

^f MACKAY MEDICAL COLLEGE   (Taiwan)

^g FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

C reactive protein; Chinese; Cross sectional study; Inflammation; Metabolic syndrome

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; HEALTH SURVEY; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; RISK ASSESSMENT; TAIWAN;

EID: 84879550528     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-012-9743-7     Document Type: Article

References (44)

1. K.G.M.M. Alberti, R.H. Eckel, S.M. Grundy, P.Z. Zimmet, J.I. Cleeman, K.A. Donato, J.C. Fruchart, W.P.T. James, C.M. Loria, S.C. Smith, Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120, 1640-1645 (2009)
2. B. Isomaa, P. Almgren, T. Tuomi, B. Forsen, K. Lahti, M. Nissen, M.R. Taskinen, L. Groop, Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24, 683-689 (2001)
3. C.M. Ballantyne, R.C. Hoogeveen, A.M. McNeill, G. Heiss, M.I. Schmidt, B.B. Duncan, J.S. Pankow, Metabolic syndrome risk for cardiovascular disease and diabetes in the ARIC study. Int. J. Obes. 32, S21-S24 (2008)
4. S.M. Haffner, The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am. J. Cardiol. 97(suppl), 3A-11A (2006)
5. M.K. Rutter, J.B. Meigs, L.M. Sullivan, R.B. D'Agostino, P.W.F. Wilson, C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham offspring study. Circulation 110, 380-385 (2004)
6. T.S. Han, N. Sattar, K. Williams, C. Gonzalez-Villalpando, M.E. Lean, S.M. Haffner, Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City diabetes study. Diabetes Care 25, 2016-2021 (2002)
7. S.E. Shoelson, L. Herrero, A. Naaz, Obesity inflammation and insulin resistance. Gastroenterology 132, 2169-2180 (2007)
8. P. Deurenberg, M. Deurenberg-Yap, S. Guricci, Asians are different from Caucasians and from each other in their body mass index/body fat percent relationship. Obes. Rev. 3, 141-146 (2002)
9. C.J. Chang, C.H. Wu, C.S. Chang, W.J. Yao, Y.C. Yang, J.S. Wu, F.H. Lu, Low body mass index but high percent body fat in Taiwanese subjects: implications of obesity cutoffs. Int. J. Obes. 27, 253-259 (2003)
10. T. Yang, C.H. Chu, C.H. Bai, S.L. You, Y.C. Chou, W.Y. Chou, K.L. Chien, L.C. Hwang, T.C. Su, C.H. Tseng, C.A. Sun, Uric acid as a risk marker for metabolic syndrome: a Chinese cohort study. Atherosclerosis 220, 525-531 (2012)
11. T. Yang T, C.H. Chu, C.H. Bai, S.L. You, Y.C. Chou, L.H. Hwang, K.L. Chien, T.C. Su, C.H. Tseng, C.A. Sun, Uric acid concentration as a risk marker for blood pressure progression and incident hypertension: a Chinese cohort study. Metabolism. doi: 10.1016/j.metabol.2012.05.006
12. J.A. Topouchian, M.A. El Assaad, L.V. Orobinskaia, R.N. El Feghali, R.G. Asmar, Validation of two devices for self-measurement of brachial blood pressure according to the International Protocol of the European Society of Hypertension: the SEINEX SE-9400 and the Microlife BP 3AC1-1. Blood Press. Monit. 10, 325-331 (2005)
13. W.L. Roberts, L. Moulton, T.C. Law, G. Farrow, M. Cooper-Anderson, J. Savory, N. Rifai, Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications, part 2. Clin. Chem. 47, 418-425 (2001)
14. W.H. Pan, K.M. Flegal, H.Y. Chang, W.T. Yeh, C.J. Yeh, W.C. Lee, Body mass index and obesity-related metabolic disorders in Taiwanese and US whites and blacks: implications for definitions of overweight and obesity for Asians. Am. J. Clin. Nutr. 79, 313-319 (2004)
15. Expert Panel on detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285, 2486-2497 (2001)
16. L.A. Bazzano, J. He, P. Muntner, S. Vupputuri, P.K. Whelton, Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann. Intern. Med. 138, 891-897 (2003)
17. M.A. Albert, R.J. Glynn, P.M. Ridker, Alcohol consumption and plasma concentration of C-reactive protein. Circulation 157, 443-447 (2003)
18. A. Festa, R. D'Agostino Jr, G. Howard, L. Mykkanen, R.P. Tracy, S.M. Haffner, Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS). Circulation 102, 42-47 (2000)
19. M. Frohlich, A. Imhof, G. Berg, W.L. Hutchinson, M.B. Pepys, H. Boeing, R. Muche, H. Brenner, W. Koenig, Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 23, 1835-1839 (2000)
20. N. Nakanishi, T. Shiraishi, M. Wada, C-reactive protein concentration is more strongly related to metabolic syndrome in women than in men: the Minoh study. Circ. J. 69, 386-391 (2005)
21. S. Bo, L. Gentile, G. Ciccone, C. Baldi, L. Benini, F. Dusio, C. Lucia, G. Forastiere, C. Nuti, M. Cassader, G. Franco Paqano, The metabolic syndrome and high C-reactive protein: prevalence and differences by sex in a southern European population-based cohort. Diabetes Metab. Res. Rev. 21, 515-524 (2005)
22. X. Ye, Z. Yu, H. Li, O.H. Franco, Y. Liu, X. Lin, Distributions of C-reactive protein and its association with metabolic syndrome in middle-aged and older Chinese people. J. Am. Coll. Cardiol. 49, 1798-1805 (2007)
23. R. Schwartz, S. Osborne-Lawrence, L. Hahner, L.L. Gibson, A.K. Gormley, W. Vongpatanasin, W. Zhu, R. Ann Word, D. Seetharam, S. Black, D. Samols, C. Mineo, P.W. Shaul, C-reactive protein downregulates endothelial NO synthase and attenuates reendothelialization in vivo in mice. Circ. Res. 100, 1452-1459 (2007)
24. H. Teoh, A. Quan, F. Lovren, G. Wang, S. Tirqari, P.E. Szmitko, A.J. Szalai, M.E. Ward, S. Verma, Impaired endothelial function in C-reactive protein overexpressing mice. Atheroslcerosis 201, 318-325 (2008)
25. W.A. Hsueh, M.J. Quinones, Role of endothelial dysfunction in insulin resistance. Am. J. Cardiol. 92, 10J-17J (2003)
26. T. Suzuki, K. Hirata, M.S. Elkind, Z. Jin, T. Rundek, Y. Miyake, B. Boden-Albala, M.R. Di Tullio, R. Sacco, S. Homma, Metabolic syndrome, endothelial dysfunction, and risk of cardiovascular events: the Northern Manhattan Study (NOMAs). Am. Heart J. 156, 405-410 (2008)
27. N. Melikian, P. Chowienczyk, P.A. MacCarthy, I.L. Williams, S.B. Wheatcroft, R. Sherwood, C. Gale, A.M. Shah, M.T. Keamey, Determinants of endothelial function in asymptomatic subjects with and without the metabolic syndrome. Atherosclerosis 197, 375-382 (2008)
28. J. Cermak, N.S. Key, R.R. Bach, G.M. Vercellotti, C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 82, 513-520 (1993)
29. U. Singh, S. Devaraj, J. Vasquez-Vivar, I. Jialal, C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling. J. Mol. Cell Cardiol. 43, 780-791 (2007)
30. E. Ferrannini, S.M. Haffner, B.D. Mitchell, M.P. Stern, Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34, 416-422 (1991)
31. G. Hotamisligil, Inflammation and metabolic disorders. Nature 444, 860-867 (2006)
32. Y. Xu, Z. Zhao, X. Li, Y. Bi, M. Xu, G. Ning, Relationships between C-reactive protein, white blood cell count, and insulin resistance in a Chinese population. Endocrine 39, 175-181 (2011)
33. R. Karnchanasorn, H.Y. Ou, L.M. Chuang, K.C. Chiu, Insulin resistance is not necessarily an essential element of metabolic syndrome. Endocrine (2012). doi: 10.1007/s12020-012-9702-3
34. S.S. Anand, F. Razak, Q. Yi, B. Davis, R. Jacobs, V. Vuksan, E. Lonn, K. Teo, M. McQueen, S. Yusuf, C-reactive protein as a screening test for cardiovascular risk in a multiethnic population. Arterioscler. Thromb. Vasc. Biol. 24, 1509-1515 (2004)
35. K.A. Matthews, M.F. Sowers, C.A. Derby, E. Stein, H. Miracle-McMahill, S.L. Crawford, R.C. Pastemark, Ethnic differences in cardiovascular risk factor burden among middle-aged women: study of Women's Health Across the Nation (SWAN). Am. Heart J. 149, 1066-1073 (2005)
36. A.J. MacGregor, J.R. Gallimore, T.D. Spector, M.B. Pepys, Genetic effects on baseline values of C-reactive protein and serum amyloid A protein: a comparison of monozygotic and dizygotic twins. Clin. Chem. 50, 130-134 (2004)
37. M.A. Mendall, P. Patel, L. Ballam, D. Strachan, T.C. Northfield, C-reactive protein and its relation to cardiovascular risk factors: a population-based cross-sectional study. Br. Med. J. 312, 1061-1065 (1996)
38. G.S. Hotamisligil, N.S. Shargill, B.M. Spiegelman, Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259, 87-91 (1993)
39. P.A. Kern, S. Ranganathan, C. Li, L. Wood, G. Ranqanathan, Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 280, E745-E751 (2001)
40. H. Baumann, J. Gauldie, Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Mol. Biol. Med. 7, 147-159 (1990)
41. I.S. Ockene, C.E. Matthews, N. Rifai, P.M. Ridker, G. Reed, E. Stanek, Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin. Chem. 47, 444-450 (2001)
42. H.K.M. Meier-Ewert, P.M. Ridker, N. Rifai, N. Price, D.F. Dinges, J.M. Mullington, Absence of diurnal variation of C-reactive protein levels in healthy human subjects. Clin. Chem. 47, 426-430 (2001)
43. P.M. Ridker, High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103, 1813-1818 (2001)
44. C.H. Tsai, T.C. Li, H.S. Tsay, Factor analysis of modifiable cardiovascular risk factors and prevalence of metabolic syndrome in adult Taiwanese. Endocrine 40, 256-264 (2011)